Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

The difference of clinicopathologic factors between FDG-avid and non-FDG-avid hepatocellular carcinoma without extrahepatic metastasis

Young Jin Jeong, Hyun Jin Yoon and Do-Young Kang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1475;
Young Jin Jeong
1Department of Nuclear Medicine, Dong-A University Medical Center, Busan, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyun Jin Yoon
1Department of Nuclear Medicine, Dong-A University Medical Center, Busan, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Do-Young Kang
1Department of Nuclear Medicine, Dong-A University Medical Center, Busan, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1475

Objectives Lots of hepatocellular carcinomas (HCC) were demonstrated as non-FDG-avid tumors regardless of the tumor size in FDG PET/CT. The aim of this study is to know the difference in clinicopathologic factors between FDG-avid and non-avid HCC.

Methods Fifty-six patients (M: F = 44: 12, 63.4 ± 8.9 years old) with nodular HCC and without extrahepatic metastasis who underwent pretreatment FDG PET/CT were enrolled. The patients were classified into two groups, FDG-avid and non-avid groups, according to FDG-avidity by visual assessment. Then the difference in imaging, clinical and pathologic factors between two groups was evaluated.

Results In FDG PET/CT, among 56 patients, HCC was detected in 39 patients (69.6%, FDG-avid group) and was not detected in 17 patients (30.4%, non-FDG-avid group). The mean size of the tumor was 6.5 ± 3.8 cm in FDG-avid group and 3.9 ± 2.7 cm in non-FDG-avid group, respectively. The mean SUVmax was 6.5 ± 3.7 (median: 5.1, range: 2.5 - 19.8) in FDG-avid group. Among the analyzed factors including sex, age, tumor size, cause of cirrhosis, AFP, PIVKA, differentiation, Child-Pugh class, death from HCC, recurrence, portal vein thrombus, tumor number, modality of treatment, SUVmax and tumor-to-background ratio, there was significant difference in tumor size (p < 0.01), cause of cirrhosis (alcohol vs virus, p = 0.04), portal vein thrombus (p = 0.04) and death from HCC (p = 0.03) in univariate analysis. Among them, tumor size (p = 0.02) and cause of cirrhosis (alcohol: virus = 7: 10 in non-FDG-avid group vs 5: 34 in FDG-avid group, p = 0.03) were significant different in multivariate analysis.

Conclusions There are significant differences in tumor size, presence of PV thrombus, death from HCC and cause of cirrhosis in univariate analysis, and tumor size and cause of cirrhosis in multivariate analysis. The etiology of liver cirrhosis could be considered as one of factors influence FDG uptake in HCC. Further studies are required in regard to the relationship between FDG-avidity and cause of cirrhosis.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The difference of clinicopathologic factors between FDG-avid and non-FDG-avid hepatocellular carcinoma without extrahepatic metastasis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The difference of clinicopathologic factors between FDG-avid and non-FDG-avid hepatocellular carcinoma without extrahepatic metastasis
Young Jin Jeong, Hyun Jin Yoon, Do-Young Kang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1475;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The difference of clinicopathologic factors between FDG-avid and non-FDG-avid hepatocellular carcinoma without extrahepatic metastasis
Young Jin Jeong, Hyun Jin Yoon, Do-Young Kang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1475;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • High detection performance and accurate staging of adrenal glands using state-of-the-art PET/CT
  • Baseline total lesion glycolysis by positron emission tomography/ computed tomography as a best prognostic parameter for patients with primary thyroid lymphoma
  • Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for cutaneous lesions from extranodal natural killer/ T-cell lymphoma
Show more Oncology: Clinical Diagnosis

MTA I: GI - Colorectal & Liver Posters

  • 18F-FDG PET independently predicts survival in patients with HCC treated with 90Y microsphere radioembolization
  • Role of prediction by residual liver function using pre-operative 99mTc-GSA scintigraphy in determination of the hepatectomy planning
  • The value of PET/CT in early predicting pathological response of locally advanced rectal cancer after neoadjuvant radiochemotherapy
Show more MTA I: GI - Colorectal & Liver Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire